Cited by CrossRef (3)

  1. Junxia Zhang, Ruqi Liang, Kai Wang, Wenjia Zhang, Mao Zhang, Li Jin, Peng Xie, Wen Zheng, Haibao Shang, Qingmei Hu, Jiayi Li, Gengjia Chen, Fujian Wu, Feng Lan, Lipeng Wang, Shi-Qiang Wang, Yongfeng Li, Yong Zhang, Jinghao Liu, Fengxiang Lv, Xinli Hu, Rui-Ping Xiao, Xiaoguang Lei, Yan Zhang. Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth. Circulation 2022;145:1154
    https://doi.org/10.1161/CIRCULATIONAHA.121.055920
  2. Sarbjit Singh, Divya Utreja, Vimal Kumar. Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy. Med Chem Res 2022;31:1
    https://doi.org/10.1007/s00044-021-02819-1
  3. Zhi-yu Zhang, Jian-hao Xu, Jiang-lei Zhang, Yu-xin Lin, Jun Ou-Yang. Pro-cancer role of CD276 as a novel biomarker for clear cell renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 2024;42:247.e1
    https://doi.org/10.1016/j.urolonc.2024.03.018
© The Korean Journal of Physiology & Pharmacology. / Powered by INFOrang Co., Ltd